Page 19 - Read Online
P. 19

endothelial growth factor production, and response to hypoxia. Am J Pathol   89.  Lyseng‑Williamson KA, Perry CM. Micronised purified flavonoid fraction:
             2003;162:303‑12.                                     a  review  of  its  use  in  chronic  venous  insufficiency,  venous  ulcers  and
          78.  Galiano RD, Tepper OM, Pelo CR, Bhatt KA, Callaghan M, Bastidas N,   haemorrhoids. Drugs 2003;63:71‑100.
             Bunting S, Steinmetz HG, Gurtner GC. Topical vascular endothelial growth   90.  Sundberg C, Nagy JA, Brown  LF, Feng  D, Eckelhoefer  IA, Manseau  EJ,
             factor accelerates diabetic wound healing through increased angiogenesis   Dvorak AM, Dvorak HF. Glomeruloid microvascular proliferation follows
             and by mobilizing and recruiting bone marrow‑derived cells. Am J Pathol   adenoviral vascular permeability factor/vascular endothelial growth factor‑164
             2004;164:1935‑47.                                    gene delivery. Am J Pathol 2001;158:1145‑60.
          79.  Weinheimer‑Haus EM, Judex S, Ennis WJ, Koh TJ. Low‑intensity vibration   91.  McCarty SM, Cochrane CA, Clegg PD, Percival SL. The role of endogenous
             improves  angiogenesis  and  wound  healing  in  diabetic  mice.  PLoS One   and exogenous enzymes in chronic wounds: a focus on the implications
             2014;9:e91355.                                       of aberrant levels of both host and bacterial proteases in wound healing.
          80.  Franzeck UK, Haselbach P, Speiser D, Bollinger A. Microangiopathy of   Wound Repair Regen 2012;20:125‑36.
             cutaneous blood and lymphatic capillaries in chronic venous insufficiency (CVI).   92.  Weitz  JI,  Byrne  J,  Clagett  GP,  Farkouh  ME,  Porter  JM,  Sackett  DL,
             Yale J Biol Med 1993;66:37‑46.                       Strandness DE Jr, Taylor LM. Diagnosis and treatment of chronic arterial
          81.  Jünger M, Steins A, Hahn M, Häfner HM. Microcirculatory dysfunction in   insufficiency  of  the  lower  extremities:  a  critical  review.  Circulation
             chronic venous insufficiency (CVI). Microcirculation 2000;7:S3‑12.  1996;94:3026‑49.
          82.  Shoab SS, Scurr JH, Coleridge‑Smith PD. Plasma VEGF as a marker of therapy   93.  Konya H, Miuchi M, Satani K, Matsutani S, Tsunoda T, Yano Y, Katsuno T,
             in patients with chronic venous disease treated with oral micronised flavonoid   Hamaguchi  T,  Miyagawa  J,  Namba  M.  Hepatocyte  growth  factor,  a
             fraction‑a pilot study. Eur J Vasc Endovasc Surg 1999;18:334‑8.  biomarker  of  macroangiopathy  in  diabetes  mellitus.  World J Diabetes
          83.  Oahues N, Philips TJ. Leg ulcers. Curr Probl Dermatol 1995;7:109‑42.  2014;5:678‑88.
          84.  Moosa HH, Falanga V, Steed DL, Makaroun MS, Peitzman AB, Eaglstein WH,   94.  Baumgartner I, Pieczek A, Manor O, Blair R, Kearney M, Walsh K, Isner JM.
             Webster MW. Oxygen diffusion in chronic venous ulceration. J Cardiovasc   Constitutive expression of phVEGF165 after intramuscular gene transfer
             Surg (Torino) 1987;28:464‑7.                         promotes collateral vessel development in patients with critical limb ischemia.
          85.  Falanga  V,  Moosa  HH,  Nemeth  AJ,  Alstadt  SP,  Eaglstein  WH.  Dermal   Circulation 1998;97:1114‑23.
             pericapillary fibrin in venous disease and venous ulceration. Arch Dermatol   95.  Lawall H, Bramlage P, Amann B. Stem cell and progenitor cell therapy
             1987;123:620‑3.                                      in  peripheral  artery  disease.  A  critical  appraisal.  Thromb Haemost
          86.  Weckroth  M,  Vaheri  A,  Virolainen  S,  Saarialho‑Kere  U,  Jahkola  T,   2010;103:696‑709.
             Sirén V. Epithelial tissue‑type plasminogen activator expression, unlike that   96.  Eming SA, Brachvogel B, Odorisio T, Koch M. Regulation of angiogenesis:
             of urokinase, its receptor, and plasminogen activator inhibitor‑1, is increased   wound healing as a model. Prog Histochem Cytochem 2007;42:115‑70.
             in chronic venous ulcers. Br J Dermatol 2004;151:1189‑96.  97.  Bauer  SM,  Bauer  RJ,  Velazquez  OC.  Angiogenesis,  vasculogenesis,
          87.  Higley  HR,  Ksander  GA,  Gerhardt  CO,  Falanga  V.  Extravasation  of   and  induction  of  healing  in  chronic  wounds.  Vasc  Endovascular  Surg
             macromolecules and possible trapping of transforming growth factor‑beta   2005;39:293‑306.
             in venous ulceration. Br J Dermatol 1995;132:79‑85.  98.  Chaplain  M,  Anderson  A.  Mathematical  modelling  of  tumour‑induced
          88.  Trent JT, Falabella A, Eaglstein WH, Kirsner RS. Venous ulcers: pathophysiology   angiogenesis:  network  growth  and  structure.  Cancer Treat Res
             and treatment options. Ostomy Wound Manage 2005;51:38‑54.  2004;117:51‑75.

















































          Plast Aesthet Res || Vol 2 || Issue 5 || Sep 15, 2015                                             249
   14   15   16   17   18   19   20   21   22   23   24